Altanib NOVA 400 mg Tablet
  1. Home
  2. Pharma Products
  3. Alkem Laboratories Ltd
  4. Altanib NOVA 400 mg Tablet

Altanib NOVA 400 mg Tablet

Altanib NOVA 400 mg Tablet contains imatinib, a targeted anticancer medicine used to treat certain types of blood cancer and gastrointestinal stromal tumors. Each tablet contains 400 mg of imatinib and is taken orally under the supervision of a qualified healthcare professional. It works by blocking specific abnormal proteins that promote the growth of cancer cells.

BUY NOW

Category

Imatinib is a tyrosine kinase inhibitor that targets abnormal signaling pathways involved in the growth and survival of certain cancer cells. It is used in conditions such as chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, and gastrointestinal stromal tumors when clinically indicated. The medicine helps control abnormal cell proliferation by inhibiting specific protein kinases, including BCR-ABL and KIT-related pathways. Treatment duration and monitoring are determined by the treating oncologist according to the patient’s diagnosis and response to therapy.

Technical Specification

Specification Details
Active Ingredient Imatinib Mesylate
Strength 400 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size Strip of 10 Tablets
Manufacturer Alkem Laboratories Ltd

Product Also Known As

Altanib NOVA 400 mg Tablet, Altanib Nova Imatinib Tablet, Imatinib 400 mg Tablet, Imatinib Anticancer Tablet, Altanib Cancer Treatment Tablet, Tyrosine Kinase Inhibitor Tablet